Tag: SNIS 2022
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
J Mocco becomes 27th Society of NeuroInterventional Surgery president
J Mocco, an endovascular neurosurgeon at Mount Sinai in New York City, USA has been named the 2022 president of the Society of NeuroInterventional...
SNIS 2022: WEB flow diverter shown to be safe and effective...
The Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) saw research involving the Woven EndoBridge (WEB; Microvention/Terumo) device disclosed for the...
SNIS 2022: Late-breaking data bolster evidence supporting thrombectomy for BAO stroke
Late-breaking research presented at the recent Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) has shown that thrombectomy procedures can...
SNIS 2022: COVID-19 may increase stroke risk in younger patients and...
Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
SNIS 2022: Direct triage to Level 1 stroke centres reduces time...
Implementing severity-based field triage leads to faster treatment and less disability for stroke patients, according to late-breaking research presented recently at the Society of...
SNIS 2022: Neuroendovascular robotics could improve safety of complex procedures
Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented at the Society of NeuroInterventional Surgery’s...
Imperative Care announces positive real-world data associated with Zoom stroke solution...
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
Rapid Medical gains US FDA clearance for “smallest and only” adjustable...
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...
Robotics, AI and other innovations in stroke and aneurysm care on...
Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...
Cerenovus announces clinical data and product showcases ahead of SNIS 2022
Cerenovus, part of Johnson & Johnson MedTech, will showcase its latest innovations in stroke care at the 2022 Society of NeuroInterventional Surgery (SNIS) annual...
Imperative Care announces poster presentations on Zoom stroke solution at SNIS...
Imperative Care has announced that new data from studies evaluating the utility of the Zoom stroke solution for the treatment of ischaemic stroke will...
